Vasyl Andrushko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vasyl Andrushko has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Armin Börner
Leibniz-Institut für Katalyse e. V
5 shared publications Natalia Andrushko
4 shared publicationsGerd König
Ratiopharm GmbH, 89070, Ulm, Germany
3 shared publicationsAndrei Korostylev
Leibniz‐Institut für Katalyse an der Universität Rostock e.V., 18059, Rostock, Germany
2 shared publicationsBenjamin Schäffner
Leibniz-Institut für Katalyse an der Universität Rostock e.V., Rostock 18059, Germany
1 shared publicationJens Holz
Leibniz-Institut für Katalyse an der Universität Rostock e.V., Rostock 18059, Germany
1 shared publication
Latest Publications
- Open Access
- 7 June 2010
- Published by Wiley in ChemCatChem
- Vol. 2 (6) , 640-643
Amination of Aliphatic Alcohols and Diols with an Iridium Pincer Catalyst
- 7 June 2010
- Published by Wiley in ChemCatChem
- Vol. 2 (6) , 640-643
Open AccessAmination of Aliphatic Alcohols and Diols with an Iridium Pincer Catalyst
Highly stereoselective hydrogenations—As key‐steps in the total synthesis of statins
Statins are inhibitors of 3‐hydroxy‐3‐methyl‐glutaryl coenzyme A reductase (HMG‐CoA reductase) and became the standard of care for treatment of hypercholesterolemia because of their efficacy, safety, and long‐term benefits. They are administered as diastereo‐ and enantiomerically pure compounds. We summarize here two new approaches for the total synthesis of the most important representatives, atorvastatin, and rosuvastatin, based on highly stereoselective hydrogenations as key‐steps. Chirality 2010.
Highly stereoselective hydrogenations—As key‐steps in the total synthesis of statins
Statins are inhibitors of 3‐hydroxy‐3‐methyl‐glutaryl coenzyme A reductase (HMG‐CoA reductase) and became the standard of care for treatment of hypercholesterolemia because of their efficacy, safety, and long‐term benefits. They are administered as diastereo‐ and enantiomerically pure compounds. We summarize here two new approaches for the total synthesis of the most important representatives, atorvastatin, and rosuvastatin, based on highly stereoselective hydrogenations as key‐steps. Chirality 2010.
Organic carbonates as alternative solvents for asymmetric hydrogenation
Organic carbonates like propylene carbonate (PC) or butylene carbonate (BC) belong to the class of aprotic, highly dipolar solvents (AHD). Interestingly, their potential as solvents for asymmetric catalysis has been overlooked for a long time. The aim of this work is to evaluate organic carbonates and other organic solvents like THF, CH2Cl2, and acetonitrile as well as members of the AHD‐family (DMF, DMSO, etc.) as media for homogeneous asymmetric hydrogenation. For this reason cationic Rh‐complexes based on chiral phosphine ligands were tested in the hydrogenation of typical benchmark substrates. In several trials, significant advantages of organic carbonates were found. In contrast to DMSO, DMF and acetonitrile, in PC and BC high conversion rates and excellent enantioselectivities were usually observed. Chirality 2009.
Organic carbonates as alternative solvents for asymmetric hydrogenation
Organic carbonates like propylene carbonate (PC) or butylene carbonate (BC) belong to the class of aprotic, highly dipolar solvents (AHD). Interestingly, their potential as solvents for asymmetric catalysis has been overlooked for a long time. The aim of this work is to evaluate organic carbonates and other organic solvents like THF, CH2Cl2, and acetonitrile as well as members of the AHD‐family (DMF, DMSO, etc.) as media for homogeneous asymmetric hydrogenation. For this reason cationic Rh‐complexes based on chiral phosphine ligands were tested in the hydrogenation of typical benchmark substrates. In several trials, significant advantages of organic carbonates were found. In contrast to DMSO, DMF and acetonitrile, in PC and BC high conversion rates and excellent enantioselectivities were usually observed. Chirality 2009.
- 6 October 2008
- Published by Elsevier in Tetrahedron Letters
- Vol. 49 (41) , 5980-5982
Synthesis of enantiopure (R)-2-(4-methoxy-3-(3-methoxypropoxy)-benzyl)-3-methylbutanoic acid—a key intermediate for the preparation of Aliskiren
- 6 October 2008
- Published by Elsevier in Tetrahedron Letters
- Vol. 49 (41) , 5980-5982
Synthesis of enantiopure (R)-2-(4-methoxy-3-(3-methoxypropoxy)-benzyl)-3-methylbutanoic acid—a key intermediate for the preparation of Aliskiren
- 28 January 2008
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2008 (5) , 840-846
Highly Enantioselective Hydrogenation of Ethyl 5,5‐Dimethoxy‐3‐oxopentanoate and its Application for the Synthesis of a Statin Precursor
The highly enantioselective hydrogenation of ethyl 5,5‐dimethoxy‐3‐oxopentanoate (3) to ethyl 3‐hydroxy‐5,5‐dimethoxypentanoate (4) – a key intermediate in the synthesis of pharmacologically important statin drugs – has been investigated. The stereochemistry of the catalytic hydrogenation of the β‐keto ester in the presence of a number of homogeneous chiral RhI and RuII complexes with phosphane ligands has been studied. The highest enantioselectivity for the homogeneous hydrogenation of 3 (up to 98.7 % ee) was achieved through an optimized version of Genêt's procedure with a Ru[(R)‐BINAP]Cl2 pre‐catalyst (substrate/catalyst ratio up to 20 000:1, 50 bar H2, 50 °C, in MeOH). The transformation of alcohol R‐(4) into ylide R‐(6) as an important precursor of the chiral side chain of rosuvastatin is also illustrated. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2008)
- 28 January 2008
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2008 (5) , 840-846
Highly Enantioselective Hydrogenation of Ethyl 5,5‐Dimethoxy‐3‐oxopentanoate and its Application for the Synthesis of a Statin Precursor
The highly enantioselective hydrogenation of ethyl 5,5‐dimethoxy‐3‐oxopentanoate (3) to ethyl 3‐hydroxy‐5,5‐dimethoxypentanoate (4) – a key intermediate in the synthesis of pharmacologically important statin drugs – has been investigated. The stereochemistry of the catalytic hydrogenation of the β‐keto ester in the presence of a number of homogeneous chiral RhI and RuII complexes with phosphane ligands has been studied. The highest enantioselectivity for the homogeneous hydrogenation of 3 (up to 98.7 % ee) was achieved through an optimized version of Genêt's procedure with a Ru[(R)‐BINAP]Cl2 pre‐catalyst (substrate/catalyst ratio up to 20 000:1, 50 bar H2, 50 °C, in MeOH). The transformation of alcohol R‐(4) into ylide R‐(6) as an important precursor of the chiral side chain of rosuvastatin is also illustrated. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2008)